Pyogenic granuloma

L12_PYOGENGRANUL

Hodgkins lymphoma: Hodgkin lymphoma (HL) is a heterogeneous group of malignant lymphoid neoplasms of B-cell origin characterized histologically by the presence of Hodgkin and Reed-Sternberg (HRS) cells in the vast majority of cases. There are two distinct subtypes: nodular lymphocyte predominant Hodgkin lymphoma and classical Hodgkin lymphoma. Hodgkin lymphoma involves primarily lymph nodes.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 L98.0
Hospital discharge: ICD-9 6861
Hospital discharge: ICD-8 68610
Cause of death: ICD-10 L98.0
Cause of death: ICD-9 6861
Cause of death: ICD-8 68610

2 out of 7 registries used, show all original rules.

425

diagram downward connector

Check minimum number of events None

425

diagram downward connector

Include endpoints None

425

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

412

diagram downward connector
L12_PYOGENGRANUL

Control definitions

Control exclude L12_OTHERSKINSUBCUTIS

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2
Parent code in ICD-10 L98
Name in latin Granuloma pyogenicum

Summary Statistics

Key figures

All Female Male
Number of individuals 412 232 180
Unadjusted prevalence (%) 0.11 0.11 0.11
Mean age at first event (years) 51.66 48.00 56.37

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: L12_PYOGENGRANUL – Pyogenic granuloma
GWS hits: 1

Survival analyses between endpoints

Plot

before Pyogenic granuloma
after Pyogenic granuloma

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Pyogenic granuloma

Endpoint not on priority list, no data to show.